Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Smith

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
The design of potent, selective, non-covalent, peptide thrombin inhibitors utilizing imidazole as a S1 binding elementM R Wiley, L C Weir, S L Briggs, et al.
Journal of Neurosurgery. Pediatrics|August 1, 2020
Safety and efficacy of brainstem biopsy in children and young adultsDavid S Hersh, Rahul Kumar, Kenneth A Moore, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
A family of arginal thrombin inhibitors related to efegatranG F Smith, R T Shuman, T J Craft, et al.
Journal of Medicinal Chemistry|March 15, 2000
N(2)-Aroylanthranilamide inhibitors of human factor XaY K Yee, A L Tebbe, J H Linebarger, et al.
Journal of Medicinal Chemistry|June 8, 2000
Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activityJ J Masters, J B Franciskovich, J M Tinsley, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of in vivo efficacyM Zhang, D L Bailey, J A Bastian, et al.
Journal of Medicinal Chemistry|March 15, 2000
1,2-Dibenzamidobenzene inhibitors of human factor XaD K Herron, T Goodson, M R Wiley, et al.
Journal of Medicinal Chemistry|February 26, 2000
Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivativesD J Sall, D L Bailey, J A Bastian, et al.
Journal of Medicinal Chemistry|November 14, 1997
Dibasic benzo[b]thiophene derivatives as a novel class of active site-directed thrombin inhibitors. 1. Determination of the serine protease selectivity, structure-activity relationships, and binding orientationD J Sall, J A Bastian, S L Briggs, et al.
Journal of Medicinal Chemistry|March 15, 2000
Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activityM R Wiley, L C Weir, S Briggs, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
The design of potent, selective, non-covalent, peptide thrombin inhibitors utilizing imidazole as a S1 binding elementM R Wiley, L C Weir, S L Briggs, et al.
Journal of Neurosurgery. Pediatrics|August 1, 2020
Safety and efficacy of brainstem biopsy in children and young adultsDavid S Hersh, Rahul Kumar, Kenneth A Moore, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
A family of arginal thrombin inhibitors related to efegatranG F Smith, R T Shuman, T J Craft, et al.
Journal of Medicinal Chemistry|March 15, 2000
N(2)-Aroylanthranilamide inhibitors of human factor XaY K Yee, A L Tebbe, J H Linebarger, et al.
Journal of Medicinal Chemistry|June 8, 2000
Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activityJ J Masters, J B Franciskovich, J M Tinsley, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of in vivo efficacyM Zhang, D L Bailey, J A Bastian, et al.
Journal of Medicinal Chemistry|March 15, 2000
1,2-Dibenzamidobenzene inhibitors of human factor XaD K Herron, T Goodson, M R Wiley, et al.
Journal of Medicinal Chemistry|February 26, 2000
Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivativesD J Sall, D L Bailey, J A Bastian, et al.
Journal of Medicinal Chemistry|November 14, 1997
Dibasic benzo[b]thiophene derivatives as a novel class of active site-directed thrombin inhibitors. 1. Determination of the serine protease selectivity, structure-activity relationships, and binding orientationD J Sall, J A Bastian, S L Briggs, et al.
Journal of Medicinal Chemistry|March 15, 2000
Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activityM R Wiley, L C Weir, S Briggs, et al.
Pageof 13